| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From Baker Medical Research Institute, Alfred Hospital, Prahran,
Victoria, Australia.
Correspondence to Dr A. Bobik, Baker Medical Research Institute, Commercial Road, PO Box 348, Prahran, Victoria 3181 Australia. E-mail Alex.Bobik{at}alice.baker.edu.au
AbstractPrevious studies have
suggested that differences in vascular smooth muscle cell (VSMC)
proliferative responses between spontaneously hypertensive rats (SHR)
and normotensive Wistar-Kyoto (WKY) rats can be attributed to
transforming growth factor-ß (TGF-ß) actions. Because vascular
collagen content is reported to be lower in SHR than in WKY rats, in
this study we investigated in cell culture whether the differences in
collagen content might also be attributed to differential actions of
TGF-ß on VSMCs from the two strains. Exposure of VSMCs from WKY to
the TGF-ß isoforms -ß1, -ß2, or
-ß3 induced rapid, transient elevations in mRNAs encoding
collagens
© 1998 American Heart Association, Inc.
Scientific Contributions
Transforming Growth Factor-ß and Receptor Tyrosine KinaseActivating Growth Factors Negatively Regulate Collagen Genes in Smooth Muscle of Hypertensive Rats
1(I),
2(I), and
1(III); maximum increases were apparent by 2 hours and
ranged from twofold [collagen
1(III)] to ninefold
[collagen
1(I)]. Thereafter they returned to near
basal levels. When VSMCs from SHR were exposed to these TGF-ß
isoforms, only reductions in collagen mRNA levels were observed,
persisting for 24 hours. Basic fibroblast growth factor and epidermal
growth factor, factors known to stimulate production of the
TGF-ß1 isoform in VSMCs, also induced a pattern of gene
responses similar to those induced by the TGF-ß isoforms in VSMCs
from SHR and WKY rats. The simultaneous presence of TGF-ß
did not affect the time course or magnitude of the changes in collagens
1(I),
2(I), or
1(III) mRNA
levels in SHR or WKY VSMCs. Examination of the induction of
c-myc mRNA and immunoreactive oncoprotein content
indicated that c-myc is a likely contributor to the
downregulation of the collagen gene activity in both SHR and WKY VSMCs
despite the differential regulation of its mRNA by TGF-ß1
in the two VSMC lines. Together these data suggest that in VSMCs from
SHR, a number of gene responses to TGF-ß, in addition to cell
proliferation, appear to be abnormal compared with WKY rats, and the
lower than normal collagen levels observed in the vasculature of SHR
may be in part due to abnormalities in TGF-ß responsiveness.
Key Words: : transforming growth factor-ß receptor proteintyrosine kinase collagen genes, c-myc muscle, smooth, vascular rats, inbred SHR
This article has been cited by other articles:
![]() |
H. D. Intengan and E. L. Schiffrin Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis Hypertension, September 1, 2001; 38(3): 581 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Gilbert, J. R. Rumble, Z. Cao, A. J. Cox, P. van Eeden, T. J. Allen, D. J. Kelly, and M. E. Cooper Endothelin Receptor Antagonism Ameliorates Mast Cell Infiltration, Vascular Hypertrophy, and Epidermal Growth Factor Expression in Experimental Diabetes Circ. Res., February 4, 2000; 86(2): 158 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Smith, S. R. Bryant, L. L. Couper, C. P. H. Vary, P. J. Gotwals, V. E. Koteliansky, and V. Lindner Soluble Transforming Growth Factor-ß Type II Receptor Inhibits Negative Remodeling, Fibroblast Transdifferentiation, and Intimal Lesion Formation But Not Endothelial Growth Circ. Res., May 28, 1999; 84(10): 1212 - 1222. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |